Stock 0575 REGENT PACIFIC GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Regent Pacific Group Ltd. Hong Kong S.E.

Equities

0575

KYG7478U1388

Pharmaceuticals

Business Summary

Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Biopharma
100.0 %
0 100.0 % 2 100.0 % +731.26%

Sales per region

HKD in Million2022Weight2023Weight Delta
Europe
83.5 %
0 31.4 % 2 83.5 % +2,108.65%
United States
12.0 %
-- 0 12.0 % -
Asia Pacific
4.5 %
-- 0 4.5 % -

Managers

Managers TitleAgeSince
Jamie Gibson CEO
 Chief Executive Officer 58 96-03-31
Jim Mellon FOU
 Founder 68 89-12-31
Yui Fui Wong DFI
 Director of Finance/CFO 49 10-12-31
Paul Eric Jones CIO
 Chief Investment Officer 59 11-03-31
Michael Wyllie CTO
 Chief Tech/Sci/R&D Officer 73 -
Jayne Allison Sutcliffe BRD
 Director/Board Member 60 89-12-31
David Samuel Church LAW
 General Counsel 49 08-08-31
Mei Yan Lui SEC
 Corporate Secretary 49 21-05-31

Members of the board

Members of the board TitleAgeSince
Jim Mellon FOU
 Founder 68 89-12-31
Jamie Gibson CEO
 Chief Executive Officer 58 96-03-31
Stawell Searle BRD
 Director/Board Member 80 01-09-30
Jayne Allison Sutcliffe BRD
 Director/Board Member 60 89-12-31
Wan Tsun Chan BRD
 Director/Board Member 45 23-04-20
Ihsan Al Chalabi BRD
 Director/Board Member 54 23-08-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 228,392,286 91,878,722 ( 40.23 %) 0 40.23 %

Holdings

NameEquities%Valuation
CONDOR GOLD PLC
0.25%
 499,000 0.25% 174,715 $
TRINITY EXPLORATION & PRODUCTION PLC
0.11%
 41,000 0.11% 24,012 $

Company contact information

Regent Pacific Group Ltd.

Henley Building 5 Queen's Road Central

, Hong Kong

+852 2514 6111

http://www.endurancerp.com
address Regent Pacific Group Ltd.(0575)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 224B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 575 Stock
  4. 0575 Stock
  5. Company Regent Pacific Group Ltd.